Growth factor stimulated receptor tyrosine kinases activate a protein kinase cascade via the serine/threonine protein kinase Raf-1. Direct upstream activators of Raf-1 are Ras and Src. This study shows that MEK1, the direct downstream eector of Raf-1, can also stimulate Raf-1 kinase activity by a positive feedback loop. Activated MEK1 mediates hyperphosphorylation of the amino terminal regulatory as well as of the carboxy terminal catalytic domain of Raf-1. The hyperphosphorylation of Raf-1 correlates with a change in the tryptic phosphopeptide pattern only at the carboxy terminus of Raf-1 and an increase in Raf-1 kinase activity. MEK1-mediated Raf-1 activation is inhibited by co-expression of the MAPK speci®c phosphatase MKP-1 indicating that the MEK1 eect is exerted through a MAPK dependent pathway. Stimulation of Raf-1 activity by MEK1 is independent of Ras, Src and tyrosine phosphorylation of Raf-1. MEK1 can however synergize with Ras and leads to further increase of the Raf-1 kinase activity. Thus, MEK1 can mediate activation of Raf-1 by a novel positive feedback mechanism which allows fast signal ampli®cation and could prolong activation of Raf-1.
Introduction
Raf-1 is a serine/threonine protein kinase (Moelling et al., 1984) which plays a central role in signal transduction pathways connecting the upstream receptor and non receptor kinases to downstream protein kinases (reviewed in Daum et al., 1994) . Growth factor stimulated receptor tyrosine kinases (RTK) activate the small GTP binding protein Ras via the adaptor molecule Grb2 and the guanine nucleotide exchange factor mSos. This is followed by the sequential stimulation of several cytoplasmic protein kinases headed by Raf-1 and collectively known as the mitogen-activated protein kinase (MAPK) signaling cascade.
Raf-1 is one member of the Raf family (Raf-1, BRaf, A-Raf) characterized by three conserved regions CR1, CR2 and CR3 (reviewed in Daum et al., 1994;  see Figure 1a ). Several proteins have been described that physically interact with Raf-1 and function as regulators or substrates for Raf-1. Activated Ras directly interacts with two binding sites located within CR1 of Raf-1 (Brtva et al., 1995) and thereby recruits the inactive cytoplasmic Raf-1 to the plasma membrane (Leevers et al., 1994; Stokoe et al., 1994) . There Raf-1 gets fully activated by additional events such as phosphorylation and interaction with lipids (Marais et al., 1995; Dent et al., 1995) . Moreover, Ras independent mechanisms and pathways that can regulate Raf activity have also been described (Dent et al., 1995; Michaud et al., 1995) . The 14-3-3 family of proteins also appears to play a role in regulation of the Raf-1 activity (Aitken, 1995; Suen et al., 1995) . Activated Ras interferes with the binding of 14-3-3 to the N-terminus but not to the C-terminus of Raf-1 (Rommel et al., 1996) . Mutations in Raf-1 which prevent binding of 14-3-3 to the N-terminus lead to an increase of the Raf kinase activity in vitro as well as in vivo as shown in a dierentiation system, the development of the compound eye of Drosophila melanogaster (Rommel et al., 1997) . Raf-1 derived peptides that prevent binding of activated Ras or 14-3-3 to Raf-1 can inhibit activation of Raf-1 and MAPK (Muslin et al., 1996; Radziwill et al., 1996) . Recently, dimerisation of Raf-1 has been shown to be involved in activation of Raf-1 kinase activity (Farrar et al.,1996; Luo et al., 1996) . Activated Raf-1 binds to and activates the dual speci®city protein kinase MEK1 (MAPK/ERK kinase). In turn, MEK1 stimulates the extracellular signal-regulated kinases, ERK1 and ERK2, which are members of the MAPK family (Kyriakis et al., 1992) . ERKs regulate the activity of cytoplasmic targets such as the ribosomal protein S6 kinase and nuclear targets such as the transcripion factors c-Jun, c-Myc and Elk-1 (reviewed in Seger and Krebs, 1995) . Recently, we have shown that Raf-1 can phosphorylate c-Jun in vitro and can physically interact with c-Jun in avian cells indicating a bypass of the MAPK dependent Jun phosphorylation (Radziwill et al., 1995) . Raf-1 can also bind and phosphorylate IkB, the inhibitor of NFkB, further indicating that Raf-1 can be directly involved in regulation of transcription (Li and Sedivy, 1993) .
Besides the association of Raf-1 with proteins such as Ras and 14-3-3 also phosphorylation of Raf-1 is involved in regulation of Raf-1 activity. Growth factor stimulation of cells results in an increase of Raf-1 phosphorylation mainly on serine residues (e.g. Ser259) and stimulation of Raf-1 kinase activity . It has been shown that protein kinase C can activate Raf-1 by phosphorylation of Ser499 (Kolch et al., 1993) whereas phosphorylation of Raf-1 by protein kinase A at Ser43 and Ser621 decreases Raf-1 kinase activity (Haefner et al., 1994; Mischak et al., 1996) . In addition, stimulation of Raf-1 activity by cytokines involves phosphorylation on tyrosine residues (Turner et al., 1991) . It has been shown that Src and Src-like kinases can bind to Raf-1 and activate it by phosphorylation of Tyr340 and Tyr341 (Cleghon and Morrison, 1994) . Moreover, Ras and Src can synergize in phosphorylation and activation of Raf-1 (Williams et al., 1992; Marais et al., 1995; Jelinek et al., 1996) . Thus, phosphorylation is an important regulation mechanism for Raf-1 kinase activity. Moreover, extracellular signals are not only mediated by linear pathways from the plasma membrane to the cytoplasm and nucleus but by a complex network with cross-talks and feedback mechanisms. For example, ERKs can also phosphorylate upstream elements such as mSos and thereby downregulate the Ras activity (Cherniack et al., 1995; Waters et al., 1995) .
In the present study the interaction between Raf-1 and its substrate MEK1 was analysed by transient expression studies in dierent cell lines. We show that the downstream eector MEK1 can mediate hyperphosphorylation of its upstream activator Raf-1 which corresponds to an increase in the Raf-1 kinase activity. MEK1-mediated activation of Raf-1 correlates with a change in the phosphopeptide pattern of the C-terminus of Raf-1. MEK1 stimulated Raf-1 activation can be inhibited by co-expression of phosphatase MKP-1 which dephosphorylates and inactivates MAPKs. This indicates that MAPKs are involved in the MEK1-mediated Raf-1 activation. The MEK1 triggered Raf-1 stimulation does not involve the Ras signalling pathway nor does it depend on Src or tyrosine phosphorylation of Raf-1. MEK1 can synergize with Ras on Raf-1 activation similar to the known synergism of Src and Ras. Thus, a positive feedback loop from activated MEK1 to Raf-1 allows a fast signal ampli®cation in addition to the activation of Raf-1 by Ras and Src.
Results

MEK1 mediates hyperphosphorylation of Raf-1 proteins
In order to study the interaction between Raf-1 and its substrate MEK1 and to investigate a possible feedback mechanism from MEK1 to Raf-1 , we used the transient transfection system in 293 cells. FLAGepitope tagged Raf-1 was co-transfected with MEK1 wild-type (MEK wt ) and constitutively activated MEK (MEK EE217/221 ) in which the activating phosphorylation sites Ser217 and Ser221 were changed to the negatively charged residue glutamate (Alessi et al., 1994) . Cells were metabolically labelled with 32 P-orthophosphate and Raf-1 proteins were analysed by immunoprecipitation using an antibody directed against the FLAGepitope. Co-expression of Raf-1 with MEK wt as well as MEK EE217/221 increased the phosphorylation of Raf-1 which correlates with a decrease of the electrophoretic mobility (Figure 1b, (Figure 1d, lanes 3 and 4) . In order to test whether MEK1 stimulated hyperphosphorylation of Raf-1 correlates with new phosphorylation sites tryptic phosphopeptide analyses were performed (Figure 2 ). MEK1-mediated phosphorylation of RafCT resulted in one additional tryptic phosphopeptide and stronger phosphorylation of another one (Figure 2b , marked by arrowheads; peptides 2 and 3 in the scheme). This is shown by comparison with the phosphopeptide pattern obtained by transfection of RafCT alone (Figure 2a ). The major spot can be attributed to Ser621 Mischak et al., 1996) (Figure 2 , peptide 1 in the scheme). To analyse whether the change in the phosphorylation pattern induced by MEK1 depends on autophosphorylation of RafCT or another kinase, the kinase-defective mutant RafCT E375 , in which lysine 375 is changed to glutamate, was tested. Comparison of the tryptic phosphopeptide patterns of RafCT E375 obtained from cells cotransfected without or with MEK EE217/221 revealed that also under these conditions activated MEK can induce phosphorylation of peptide 2 and stronger phosphorylation of peptide 3 (Figure 2c and d). This demonstrates that the MEK1-induced phosphorylation of RafCT at peptide 2 and increased phosphorylation of peptide 3 do not depend on autophosphorylation indicating phosphorylation of RafCT by another kinase. Moreover, stimulation of cells with EGF also induced phosphorylation of RafCT at peptide 2, suggesting that this site is also normally targeted during growth factor stimultion (data not shown). In addition, tryptic phosphopeptide maps of the N-terminal fragment of Raf-1 expressed alone or co-expressed with MEK EE217/221 were compared. In this case the hyperphosphorylation does not result in novel tryptic phosphopeptides (data not shown).
Taken together, these data indicate that MEK1 mediates hyperphosphorylation of the N-and Cterminus of Raf-1. The appearance of a new phosphorylation site and the intensi®ed phosphorylation of another one is independent of autophosphorylation and must be attributed to another kinase phosphorylating the RafCT. This suggests that MEK1 could be involved in the regulation of the Raf-1 activity by inducing hyperphosphorylation at the Nterminal regulatory domain as well as the C-terminal catalytic domain.
MEK1 mediated hyperphosphorylation of Raf-1 correlates with increased Raf-1 kinase activity
In most cases hyperphosphorylation of Raf-1 correlates with an increase in its kinase activity. To study whether co-expression of MEK1 which stimulate hyperphosphorylation of Raf-1 can in¯uence Raf-1 kinase activity immunopuri®ed Raf-1 was analysed in an in vitro kinase assay with the kinase inactive GST-MEK K97R protein as substrate. Similar amounts of Raf-1 proteins were immunoprecipitated as controlled by immunoblotting with aFlag antibody (data not shown).
First, RafCT was tested which by itself has an increased kinase activity compared to Raf-1 wild-type because of the truncation of the negatively regulating N-terminal domain. However, it has been shown that RafCT can still be regulated and overexpression of activated Src eciently stimulates its Raf kinase activity (Haefner et al., 1994; Marais et al., 1995) . As shown in Figure 3a RafCT kinase activity could be increased by MEK wt as well as MEK EE217/221 (14-and 11-fold, respectively), whereas activated Src Porthophosphate and the FLAG-epitope tagged Raf-1 proteins were immunoprecipitated with an aFLAG antibody, subjected to SDS ± PAGE and visualized by a PhosphorImager stimulated the kinase activity of the wild-type Raf-1 protein but to less extent (two-and sixfold, respectively; Figure 3b ). This is comparable to the stimulation of serum starved cells by EGF (fourfold) but is much less than the stimulation observed by coexpression of activated Ras V12 (25-fold). Interestingly, the MEK wt and MEK EE217/221 induced stimulation synergized with Ras V12 and resulted in a maximal activation of Raf-1 (47-and 44-fold) comparable to the eect seen by co-expression of Raf-1 with Ras V12 and Src F527 (50-fold). These data provide evidence that MEK1 can stimulate Raf-1 kinase activity presumably by a positive feedback mechanism. Activation of RafCT by MEK1 is similar to that of Src F527 and co-expression of both activators together does not further increase RafCT kinase activity (data not shown). On the other hand, MEK1-induced Raf-1 kinase activity can be drastically increased by Ras V12 indicating a synergism between MEK1 and Ras which is comparable to the known cooperativity between Ras and Src on Raf-1 activation.
MEK1 stimulated Raf-1 kinase activity is independent of Ras
Activation of Raf-1 in the receptor tyrosine kinase pathway depends on recruitment of Raf-1 to the plasma membrane by activated Ras. Therefore, mutant proteins interfering with the Ras signalling pathway were tested for their in¯uence on the MEK1-mediated Raf-1 activation. First, the mutant Raf-1 protein Raf L89 , which cannot interact with Ras, was tested ( Figure 4) . MEK EE217/221 stimulated the kinase activity of Raf-1 wild-type as well as Raf L89 to a similar extent. In contrast, Ras V12 induced Raf-1 activation was strongly reduced in the case of Raf L89 , since this mutant fails to physically interact with Ras (Fabian et al., 1994; Niehof et al., 1994) . Secondly, the eect of the dominant negative mutant Ras N17 was tested (Figure 4) . MEK EE217/221 -mediated stimulation of Raf-1 kinase activity was not inhibited by co-expression of Ras N17 , in contrast to EGF stimulated Raf-1 kinase Porthophosphate. RafCT proteins were immunoprecipitated, resolved by SDS ± PAGE and subjected to two-dimensional tryptic phosphopeptide analysis. Phosphopeptides obtained after tryptic digestion were spotted on thin layer chromatography plates and separated by electrophoresis (horizontal direction) and subsequent chromatography (vertical direction). The origin is indicated by a dot. Identical amounts of radioactivity were loaded. In the scheme peptide 1 represents Ser621. , Ras V12 or Src F527 was performed as described in Materials and methods. Additionally, serum starved cells overexpressing FLAG-Raf full length were stimulated with EGF (100 ng/ml, 7 min). The kinase activity of immunoprecipitated FLAG-RafCT (a) and FLAG-Raf full length (b) was measured by in vitro kinase assays using recombinant kinaseinactive GST-MEK as a substrate. The phosphorylated reaction products were separated by SDS ± PAGE and analysed using a PhosphorImager. To show that activation of Raf-1 depends on phosphorylation RafCT immunocomplexes were treated with the phosphatase PP2A prior to in vitro kinase assay. The results are shown as the relative kinase activity compared to the basal kinase activity of FLAG-RafCT or FLAG-Raf-1. Indicated are the means and standard deviations from at least three independent experiments activity which was reduced by Ras
N17
. Both experiments together clearly demonstrate that the MEKmediated Raf1 activation is independent of Ras activity.
MEK1-induced RafCT kinase activity is independent of tyrosine phosphorylation
Recently it has been shown that Src and Src-like kinases can phosphorylate two adjacent tyrosine residues at the C-terminus of Raf-1 (residues 340 and 341) and thereby can stimulate Raf-1 kinase activity (Fabian et al., 1993) . This raised the question of whether MEK1-mediated activation of Raf-1 depends on phosphorylation of Raf-1 on tyrosine residues. Therefore, the Raf-1 mutant Raf FF340/341 in which the two known tyrosine phosphorylation sites were replaced by phenylalanine was cotransfected with MEK EE217/221 (Figure 5a ). Activated MEK1 can still activate Raf FF340/341 while Src F527 failed to activate this mutant. Substitution of the tyrosine residues 340 and 341 to phenylalanine reduced the Ras-dependent activation of Raf-1 to the level obtained by MEK EE217/221 indicating that in some way these two tyrosine residues are involved in Ras-dependent signalling. Moreover, coexpression of Src M297 , a dominant negative mutant of Src, did not interfere with the MEK-mediated activation of Raf-1 ( Figure  5a ). To test whether MEK1 can mediate phosphorylation of Raf-1 on tyrosine residues at all, phosphoamino acid analyses were performed (Figure 5b ). 293 cells expressing RafCT were labelled metabolically with 32 Porthophosphate. Cells lysates were fractionated in a membrane (P100) and a cytoplasmic fraction (S100) and RafCT was immunoprecipitated from both fractions. Phosphoamino acid analysis showed that RafCT co-expressed with MEK EE217/221 was phosphorylated mainly on serine and to some extent on threonine. In contrast, RafCT co-expressed with Src showed in addition phosphorylation on tyrosine. Same results were obtained for RafCT isolated from the membrane fraction and from the cytoplasm. Taken together, these data indicate that Src and phosphorylation of Raf-1 on tyrosine residues by other tyrosine kinases are not involved in MEK-mediated hyperphosphorylation and stimulation of Raf-1 kinase activity.
MKP-1 inhibits MEK1 mediated Raf-1 activation
MEK1 functions as an upstream activator of the MAPKs ERK1 and ERK2. The kinase activity of ERK can be downregulated by the dual speci®city phosphatase MKP-1 which dephosphorylates the threonine and tyrosine residue phosphorylated by MEK1 (reviewed in Nebrada, 1994). To test whether Figure 4 MEK1-mediated activation of Raf-1 is independent of Ras. Cells were co-transfected with plasmids coding for FLAGRaf or the mutant FLAG-Raf L89 alone or with Ras V12 , MEK EE217/ 221 and dominant negative Ras N17 as indicated. The kinase activity of Raf-1 and Raf L89 was assayed as described in Figure 3 . Dominant negative Ras N17 was able to reduce the EGF mediated (100 ng/ml, 7 min) Raf-1 activity but not the MEK and Raf-1 resulted in hyperphosphorylation of ERK2 as evidenced by the appearance of a protein doublet in SDS ± PAGE and in phosphorylation of MBP in cellular lysates. MKP-1 prevented ERK2 hyperphosphorylation and also reduced phosphorylation of MBP indicating that ERK2 and other MBP phosphorylating kinases were inactivated. Thus, expression of MKP-1 inhibits MEK1-mediated activation of ERK and Raf-1. This indicates that the MEK1-induced positive feedback on Raf-1 may act through ERK, a common substrate for MEK1 and MKP-1.
Discussion
We demonstrate that MEK1 mediates hyperphosphorylation of Raf-1 and leads to stimulation of the Raf-1 kinase activity. Thus, the Raf-1 substrate MEK1 is involved in a positive feedback mechanism. This MEK1-triggered activation of Raf-1 is independent of the known upstream activators Ras and Src. The downstream eectors of MEK1, ERK1 and ERK2, must play a role since the phosphatase MKP-1, which can inactivate MAPKs, also downregulates the MEK1 mediated Raf-1 activation. A model for the MEK1-mediated positive feedback loop is shown in Figure 7 . Recently, it has been shown that MEK1 and ERK can also initiate negative feedback mechanisms which downregulate Ras activity and subsequently Raf-1 activity (Cherniak et al., 1995; Waters et al., 1995) . In this case, the guanine nucleotide exchange factor mSos is phosphorylated by ERK or by an ERKindependent manner through MEK1 (Cherniak et al., 1995; Ueki et al., 1994; Holt et al., 1996) . Hyperphosphorylation of mSos results in the dissociation of the Grb2-mSos complex that is formed after growth factor stimulation of cells and is essential for Ras activation. The positive feedback described here is independent of Ras activity. This is demonstrated by the mutant proteins Ras N17 and Raf L89 which interfere with Ras signalling but do not aect MEK1-mediated Raf-1 activation. Moreover, transient expression of activated MEK1 does not result in a hyperphosphorylation of endogenous mSos (data not shown). Interestingly, the MEK-triggered Raf-1 stimulation is not only independent of Ras but also of tyrosine phosphorylation. Tyrosine phosphorylation and activation of Raf-1 has been described for Src and Src-like kinases (Cleghon and and is involved in stimulation of -mediated Raf-1 activation (sixfold) was reduced by co-expression of MKP-1 (1.5-fold). Cell lysates were either directly subjected to SDS ± PAGE and immunoblotted with an aErk-2 antibody (middle panel) or were assayed for MAP kinase activity using MBP as a substrate (lower panel). MEK1-mediated MBP-phosphorylation (ninefold) was reduced by coexpression of MKP-1 (1.5-fold).
Figure 7
Model of feedback mechanisms acting on Raf-1. Pathways which have previously been described to be involved in the downregulation of Raf-1 kinase activity are indicated to the left. These negative feedback events emerge from either ERK or MEK1 and act via mSos and Ras. In this study, however, a positive feedback is described which is mediated by MEK1 and is independent of Ras and Src. The role of ERK is proven by the fact that the MAPK-speci®c phosphatase, MKP-1, can antagonize the MEK1-induced stimulation of Raf-1. Presumably an additional unknown factor(s) (X) may play a role cells with cytokines (Turner et al., 1991) . However, as shown here a dominant negative Src mutant cannot inhibit MEK1-mediated Raf-1 activation. Also the Raf-1 mutant Raf FF340/341 , which can no longer be activated by Src and Src-like kinases, can still be activated by MEK1. In addition, hyperphosphorylation of RafCT stimulated by MEK1 does not result in phosphorylation on tyrosine as shown by phosphoamino acid analysis. Thus, the positive feedback on Raf-1 is independent of Ras and Src whereas the negative feedback acts through Ras on Raf-1 (see Figure 7) . But both, the positive and negative feedback mechanisms, depend on MEK1 and ERK. Therefore, the time course of the stimulus as well as dierent factors might be important to determine which feedback loop is activated.
MEK1 mediates hyperphosphorylation of the N-as well as the C-terminus of Raf-1 and hyperphosphorylation of RafCT led to the appearance of a new phosphopeptide and to stronger phosphorylation of another one. Since coexpression of activated MEK1 did not result in dierences between the tryptic phosphopeptide pattern of RafCT and the kinasedefective RafCT E375 , the autophosphorylation activity of RafCT is not responsible for these changes. The additional new phosphorylation site was also detectable upon EGF stimulation indicating that it is normally targeted during growth factor stimulation. The increased phosphorylation of one of the peptides could be speci®c for the positive feedback induced by MEK1. A MEK1-induced phosphorylation of the serine residues 621 and 624 leading to a mobility shift of Raf-1 has recently been described by Ferrier et al. (1997) , however, activation of Raf-1 by MEK1 was not addressed.
Previously, it has been shown that ERK can phosphorylate Raf-1 in vitro (Anderson et al., 1991; Kyriakis et al., 1993) and in a cell-line overexpressing ERK the stimulation of hyperphosphorylation of Raf-1 was enhanced (Ueki et al., 1994) , whereby an in¯uence on Raf-1 kinase activity was not detectable. Recently, Alessandrini et al. showed that in some clonal cell lines stably expressing constitutively activated MEK the kinase activity of Raf-1 and ERK can be increased (Alessandrini et al., 1996) . The data presented here demonstrate that the MEK1 mediated Raf-1 activation is antagonized by expression of the phosphatase MKP-1 indicating that ERK plays a role in the positive feedback loop. Therefore, we postulate that there must be an additional kinase(s) between ERK and Raf-1 which contribute to phosphorylation and activation of Raf-1. Because ERK can regulate transcription by phosphorylation of transcription factors such as Elk-1 and Myc, it might be possible that ERK induces an autocrine loop which results in activation of Raf-1. In the MEK1-mediated positive feedback this autocrine mechanism would be independent of Ras, Src and tyrosine phosphorylation of Raf-1. Therefore, a possible autocrine loop would not involve growth factor and cytokine stimulated pathways because these are dependent on Ras and Src or Src-like kinases, respectively. Incubation of Raf-1 transfected cells with medium collected from Raf-1 and MEK1 overexpressing cells did not increase Raf-1 kinase activity, even with medium collected 24 h after transfection (data not shown). Thus, it is unlikely that secreted factors lead to an autocrine loop involved in MEK1-mediated Raf-1 activation. In order to rule out that E1A or E1B proteins, which are expressed in the Adenovirus-transformed 293 cell-line used here, are responsible for the MEK1-induced Raf-1 activation, we performed similar experiments in COS cells. Expression of activated MEK in COS cells also induced the positive feedback loop on Raf-1 as was the case in 293 cells (data not shown).
In the positive feedback described here the ®rst step is the activation of MEK1. This can either be achieved by using the activated mutant MEK EE217/221 or by using RafCT or the mutant Raf A259 (data not shown) both of which exhibit a moderate but constitutive kinase activity . A weak activation signal on MEK1 might be sucient for further activation of Raf-1 by the positive feedback loop which could prolong the duration of Raf-1 activitation. The MEK1 stimulated Raf-1 kinase activity can be further increased by Ras. This means that although MEK1 can stimulate Raf-1 independently of Ras, it can act synergistically with activated Ras. This is similar to the known synergism of Ras and Src on Raf-1 activation. It is of interest that besides Raf-1 there also exist other activators for MEK1 such as Mos (Posada et al., 1993) or MEKK (Lange-Carter et al., 1993) . Therefore, under certain conditions MEK1 might be activated through pathways which do not involve Raf-1. These could still lead to stimulation of Raf-1 by the positive feedback mechanism described in this study. We are currently trying to identify further factors essential for the MEK1-mediated positive feedback loop. Our results point to a cross-talk and an ampli®cation mechanism between various signalling pathways which are under control of dierent stimuli.
Materials and methods
Plasmids
The plasmids pcDNA3FLAG-Raf, pcDNA3FLAG-RafNT, pcDNA3FLAG-RafCT and pcDNA3FLAG-RafCT E375 have been described recently (Rommel et al., 1996) . pcDNA3FLAG-Raf L89 (exchange of Arg89 to Leu) and pcDNA3FLAG-Raf FF340/341 (exchange of Tyr340/341 to Phe) were generated using the QuickChange site-directed mutagenesis kit (Stratagene). The cDNAs coding for oncogenic Ras V12 (exchange of Glu12 to Val) and for dominant negative Ras N17 (exchange of Ser17 to Asn) were a gift from Dr A Wittinghofer (Feig et al., 1986; John et al., 1988) and were subcloned into pCis2 (Rommel et al., 1996) . cDNAs for activated Src F527 (exchange of Tyr527 to Phe) and for dominant negative Src M297 (exchange of Lys297 to Met) were obtained from Drs T Hunter and M Broome (de Hertog et al 1994) and were subcloned into pcDNA3 (Invitrogen). The rabbit wild-type MEK1 and the constitutively active mutant MEK EE217/221 (exchange of Ser217/221 to Glu) inserted in the vector pBABEpuro were kindly provided by Dr C J Marshall (Alessi et al., 1994) and subcloned into pcDNA3. The cDNA for the human MAPK phosphatase MKP-1 (CL100) was a gift from Dr S Keyse (Keyse and Emslie, 1992) and was subcloned into pcDNA3.
Cell culture and transfection
Adenovirus 5 E1A/B transformed human embryonic kidney cells (293 cells) were grown at 378C and 10% CO 2 in Dulbecco's modi®ed Eagles medium (DMEM/GIBCO-BRL). The medium was supplemented with 4mM glutamine, 100 units/ml penicillin, 100 mg/ml streptomycin and 10% fetal calf serum (FCS). 293 cells were transiently transfected at a con¯uency of 80% using the Lipofectamine reagent transfection system (GIBCO-BRL) as described (Rommel et al., 1996) . The transfection medium was replaced after 8 h by DMEM containing 10 % FCS to allow another 12 ± 14 h expression of the transfected plasmids.
Metabolic labelling with 32 P-orthophosphate
In vivo labelling of the cells was performed as described previously (Radziwill et al., 1995) . Transfected cells were rinsed once with phosphate-free medium and were then incubated for 2 h in phosphate-free DMEM supplemented with 4mM glutamine and 10% dialysed FCS. Subsequently, the cells were labelled for 3 h with 0.3 mCi/ml 32 Porthophosphate in the presence of 10% dialysed FCS. Afterwards, the plates were washed with 3 ml of ice-cold phosphate-buered saline solution (PBS) containing 1 mMDTT, 1 mM PMSF, 200 KIE/ml Trasylol (Bayer), 40 mM b-glycerophosphate, 1 mM Na-orthovanadate, 25 mM NaF, 1 mM benzamidine, 1 mg/ml pepstatin and 1 mg/ml leupeptine and scraped in 0.8 ml PBS. The cells were harvested by centrifugation (8 min, 1500 r.p.m.) and lysed in 0.75 ml RIPA buer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% SDS, 0.5% DOC, 1% Triton X-100, 2 mM EDTA, 10% Glycerol and inhibitors as above). Precleared lysates were incubated with aFLAG antibody (M2, IBI/ Kodak) and rotated for 2 h at 48C. The immunoprecipitates were washed four times in RIPA buer and heated for 5 min in SDS sample buer. After SDS-polyacrylamide gel electrophoresis the proteins were analysed by autoradiography using a PhosphorImager.
Two-dimensional tryptic phosphopeptide mapping and phosphoamino acid analysis
The FLAG-RafCT was immunoprecipitated from 32 Porthophosphate labelled 293 cells, resolved by SDS ± PAGE and subjected to two-dimensional tryptic phosphopeptide analysis as described previously (Schramm et al., 1994) . For phosphoamino acid analysis the cells were labeled as above, washed and lysed in hypotonic lysis buer (HLP) (10 mM Tris-HCl, pH 7.5, 10 mM NaCl, 3 mM MgCl 2 , 0.2 mM EDTA, 1 mM DTT, 1 mM PMSF, 200 KIE/ml Trasylol (Bayer), 40 mM b-glycerophosphate, 0.2 mM Na-orthovanadate, 25 mM NaF, 1 mM benzamidine and 1 mg/ml leupeptine). Cells were broken by 50 strokes with a Dounce homogenizer and centrifuged (15 min, 3000 r.p.m.) to pellet nuclei. The supernatant was ultracentrifuged at 100 000 g for 45 min to separate the lysate into a membrane fraction (P100) and a cytosolic fraction (S100). The pellet was extracted with modi®ed HLP, containing 1% NP-40 and 100 mM NaCl, whereas the cytosolic fraction was adjusted to 1% NP-40 and 100 mM NaCl. Both fractions were precleared with sepharose beads and subsequently immunoprecipitated. The precipitates were subjected to SDS ± PAGE. FLAGRafCT was excised from the gel and subsequently treated according to the protocol of Boyle et al., 1991 . The radiolabeled tryptic phosphopeptides and phosphoamino acids were visualized by a PhosphorImager.
In vitro kinase assay
Cells were starved for at least 8 h and in some cases stimulated with EGF (Sigma) at a concentration of 100 ng/ ml for 7 min. Lysis of the cells and immunoprecipitation were performed as described above. Except, after immunoprecipitation the beads were washed 3 times in RIPA buer and two times in kinase buer (50 mM TrisHCl, pH 7.5, 50 mM NaCl, 7.5 mM MnCl 2 , 2 mM DTT, 25 mM b-glycerophosphate). For in vitro dephosphorylation Raf-immunocomplexes were washed once in phosphatase dilution buer (20 mM MOPS, pH 7.5, 60 mM 2-mercaptoethanol, 1 mM MgCl 2 , 0.1 mg/ml serum albumin) and incubated in 30 ml dilution buer with 0.5 Units of Protein Phosphatase Type-2A (PP2A) (UBI, Lake Placid). After 15 min at 308C PP2A treated immunocomplexes were washed two times with kinase buer. To suppress the autophosphorylation of Raf-1 the precipitates were preincubated with 50 ml kinase buer containing 20 mM ATP for 8 min at room temperature. In vitro kinase assays were performed by incubating the immunocomplexes in 30 ml kinase buer containing 10 mCi [g-32 P]ATP (Amersham) and 1 mg of recombinant kinase-inactive GST-MEK K97A for 30 min at 308C. The reaction was stopped by adding 10 ml 46 SDS-sample buer and heating the samples at 958C for 5 min. After SDS ± PAGE the quanti®cation of radioactivity incorporated into GST-MEK K97A was carried out with a PhosphorImager. The puri®cation of the recombinant kinase-inactive GST-MEK K97A as a substrate for Raf proteins has been described elsewhere .
ERK2 immunoblot and MAP kinase activity assay
Cells were transfected as described above and starved for 6 h. Prior to lysis, cells were washed with 2 ml ice-cold PBS and resuspended in 300 ml MAP kinase buer (20 mM TrisHCl, pH 7.5, 1 mM EGTA, 10 mM MgCl 2 , 2 mM MnCl 2 , 0.1% NP-40, 1 mM PMSF, 1 mM pepstatin, 200 KIE/ml Trasylol). Cells were broken by passing them 10 times through a 25-gauge needle. The lysates were cleared by centrifugation and aliquots were resolved by SDS ± PAGE. After electrophoresis the proteins were blotted onto nitrocellulose membranes. The ®lter was probed with a polyclonal aERK2 antibody (UBI) overnight at 48C and the ERK2 proteins were visualised with the ECL detection system (Amersham). For measurement of MAP kinase activity cellular extracts containing 30 mg protein were incubated with 20 mg myelin basic protein (Sigma), 10 mM ATP and 2 mCi of [g-32 P]ATP for 20 min at 308C. The reaction was stopped with 46 SDS-sample buer, boiled for 5 min and the samples were resolved by 15% SDS ± PAGE. MBP-phosphorylation was evaluated with a PhosphorImager.
